UNITED THERAPEUTICS Corp (UTHR) bonds
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)
Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
United Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in United Therapeutics's 10-Q for the period ended Jun 30, 2026
United Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| 2025 Credit Agreement | $2.50B | $0 |
| First Unsecured Revolving Credit Facility | $1.20B | – |
| Second Unsecured Revolving Credit Facility | $800.00M | – |
See a number that looks wrong?